Newport, RI, United States of America

Christopher Bowley

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
4 patents (USPTO):

Title: The Innovative Mind of Christopher Bowley

Introduction

Christopher Bowley, an accomplished inventor based in Newport, RI, is recognized for his significant contributions to medical technology. With a total of three patents to his name, Bowley has focused on developing innovative solutions aimed at addressing critical medical challenges, particularly in hemostasis.

Latest Patents

Among Bowley's latest patents is the "Flowable Hemostatic Suspension," which describes compositions and methods related to flowable hemostats that crosslink during and/or after application to a bleeding site. This innovative approach enhances the efficacy of hemostatic agents in emergency medical situations. Additionally, he holds a patent for the "Reactive Polysaccharide-Based Hemostatic Agent," which outlines compositions and methods for powdered hemostats that similarly crosslink during and/or post-application, providing vital solutions for controlling bleeding in surgical environments.

Career Highlights

Christopher Bowley has made a name for himself within the medical device industry through his work at Davol Inc. His focus on breakthroughs in hemostatic agents showcases his dedication to improving medical practices. Through his inventions, Bowley has played a crucial role in advancing surgical procedures and patient outcomes.

Collaborations

Throughout his career, Bowley has collaborated with talented professionals like Keith Greenawalt and Jessica Powell, who have contributed to the development of his innovative products. These collaborations highlight the importance of teamwork in bringing forth groundbreaking medical solutions.

Conclusion

Christopher Bowley exemplifies the spirit of innovation within the medical device field. His patents reflect a commitment to enhancing surgical safety and effectiveness through advanced hemostatic methods. As he continues his work at Davol Inc., Bowley remains a pivotal figure in the quest to improve patient care and medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…